Physician profile
Peter A Zeman
NPI 1730173287
$16,878.72
in general payments reported to CMS, 2019-2025
50 companies · $3,169 in 2025
The $3,169 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $1,023 · 2021: $2,081 · 2022: $3,410 · 2023: $3,010 · 2024: $3,388 · 2025: $3,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,532 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,532.14 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $5,138.39 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $1,651.98 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,220.60 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $1,204.36 | 2019-2025 | Erleada |
| Pfizer INC. | $1,014.78 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $728.16 | 2019-2025 | |
| Accord Healthcare, INC. | $599.25 | 2022-2025 | |
| Urogen Pharma, INC. | $381.64 | 2021-2025 | Jelmyto |
| Abbvie INC. | $379.08 | 2019-2025 | Botox |
| Myovant Sciences INC. | $314.75 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $308.26 | 2019-2024 | Xiaflex, Aveed |
| 180 Medical, INC. | $298.93 | 2019-2025 | Gentlecath, Gentlecath Glide, Cure Ultra Catheter |
| Endo USA, INC. | $296.84 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $269.19 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Merck Sharp & Dohme LLC | $267.38 | 2021-2025 | Keytruda, Lynparza, Welireg |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $218.00 | 2020-2025 | Lynparza, Imfinzi |
| Coloplast Corp | $190.32 | 2021-2025 | |
| Blue Earth Diagnostics | $168.57 | 2020-2025 | Posluma |
| Amgen INC. | $166.30 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $163.05 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $158.05 | 2021-2022 | |
| Boston Scientific Corporation | $150.58 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Axonics |
| Novartis Pharmaceuticals Corporation | $150.19 | 2022-2025 | |
| Procept Biorobotics Corporation | $143.96 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Teleflex LLC | $126.94 | 2022-2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $119.95 | 2021-2022 | |
| Immunitybio, INC. | $111.20 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $102.89 | 2022-2025 | Trelstar |
| Axonics, INC. | $90.43 | 2021-2023 | Axonics |
| Sun Pharmaceutical Industries INC. | $62.19 | 2021-2023 | Yonsa |
| Allergan, INC. | $61.13 | 2019-2021 | |
| Olympus America INC. | $56.99 | 2021-2025 | Itind System |
| Azurity Pharmaceuticals, INC. | $54.98 | 2025 | Azmiro |
| Smith+Nephew, INC. | $50.93 | 2021-2025 | Stravix |
| Tempus Ai, INC | $48.56 | 2025 | Xt Cdx |
| Photocure INC | $47.71 | 2023-2025 | Cysview |
| Angiodynamics, INC. | $40.54 | 2022-2024 | Nanoknife |
| Progenics Pharmaceuticals, INC. | $37.65 | 2024 | |
| Palette Life Sciences, INC. | $37.61 | 2022 | |
| Hollister Incorporated | $33.18 | 2022-2023 | Infyna Chic, Onli, Vapro |
| Halozyme INC | $31.62 | 2023 | |
| Acerus Pharmaceuticals Corporation | $26.08 | 2020-2021 | |
| Zyla Life Sciences, INC. | $25.74 | 2020 | |
| Laborie Medical Technologies Corp. | $23.95 | 2020 | |
| Foundation Medicine, INC. | $21.45 | 2021 | |
| Medtronic USA, INC. | $20.51 | 2020 | |
| Telix Pharmaceuticals | $18.84 | 2024 | Illuccix |
| Cardinal Health 414 LLC | $17.88 | 2024 | |
| Argon Medical Devices, INC. | $13.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.20 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Zeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.